J. Jacobson

No ORCID on file · 4 papers in corpus · active 1988-1997

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
article 1997
A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513599709152533

The objective of this study was to compare the efficacy of nafarelin 200 micrograms (Group A), nafarelin 400 micrograms (Group B) and the combination of nafarelin 200 micrograms and norethisterone 1.2 mg (Group C) daily, in treating symptom…

other 1994
Low dose intranasal nafarelin for the treatment of endometriosis
Acta obstetricia et gynecologica Scandinavica ·doi:10.3109/00016349409013417

Twenty-five women with regular menstruation and laparoscopically confirmed endometriosis received 100 mcg nafarelin intranasally twice daily for six months in an open study. American Fertility Society (AFS) laparoscopic scores pre- and post…

article 1990
Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists?
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-70-4-920

Recent studies have shown that treatment with the LHRH agonist nafarelin gives symptomatic and objective relief to women with endometriosis. Such a treatment, however, results in increased bone turnover and loss of bone mass. In the present…

article 1988
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
The New England journal of medicine ·doi:10.1056/nejm198802253180805

Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces hypoestrogenemia. To determine the efficacy of such hormonal manipulation in the treatment of endometriosis, we randomly as…